Parcourir Faculté de pharmacie – Travaux et publications par auteur·e "Tamimi, Faleh"

Voici les éléments 1-3 de 3

  • Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer’s patients 

    Al-Hamed, ‪Faez Saleh; Kouniaris, Stamatis; Tamimi, Iskandar; Lordkipanidzé, Marie; Madathi, Sreenath Arekunnath; Kezouh, Abbas; Karp, Igor; Nicolau, Belinda; Tamimi, Faleh (2021-08-20)
    Introduction: Acetylcholinesterase inhibitors (AChEIs) are commonly used to treat mild to moderate cases of Alzheimer disease (AD). To the best of our knowledge, there has been no study estimating the risk of bleeding and cardiovascular events in ...

  • Differences in platelet-rich plasma composition influence bone healing 

    Al-Hamed, Faez Saleh; Abu-Nada, Lina; Rodan, Rania; Sarrigiannidis, Stylianos; Ramirez-Garcialuna, Jose Luis; Moussa, Hanan; Elkashty, Osama A.; Gao, Qiman; Basir, Tayebeh; Baca, Laura; Torres, Jesus; Rancan, Lisa; Tran, Simon D.; Lordkipanidzé, Marie; Kaartinen, Mari; Badran, Zahi; Tamimi, Faleh (Wiley, 2021)
    Aim: Platelet-rich plasma (PRP) is an autologous blood-derived material that has been used to enhance bone regeneration. Clinical studies, however, reported inconsistent outcomes. This study aimed to assess the effect of changes in leucocyte and ...

  • Postoperative administration of the acetylcholinesterase inhibitor, donepezil, interferes with bone healing and implant osseointegration in a rat model 

    Al-Hamed, ‪Faez Saleh; Maria, Ola M.; Phan, Jeff; Al Subaie, Ahmed; Gao, Qiman; Mansour, Alaa; Abu Nada, Lina; Boukhatem, Imane; Elkashty, Osama A.; Tran, Simon D.; Lordkipanidzé, Marie; Badran, Zahi; Tamimi, Faleh (MDPI, 2020-09-14)
    Donepezil is an acetylcholinesterase inhibitor commonly used to treat mild to moderate Alzheimer’s disease. Its use has been associated with increased bone mass in humans and animals. However, the effect of postoperative administration of donepezil on ...